[Parkinson disease and amyotrophic lateral sclerosis. Tauopathies, TDP-43 and SOD mutations]

Rev Neurol (Paris). 2009 Jan;165(1):15-30. doi: 10.1016/j.neurol.2008.02.043. Epub 2008 Jun 24.
[Article in French]

Abstract

In addition to a large number of clinical descriptions of atypical cases, recent pathological, biochemical and genetic studies challenge the view that amyotrophic lateral sclerosis (ALS) is a disorder restricted to the pyramidal motor system. Relations between ALS, Parkinson disease, fronto-temporal dementia, progressive supranuclear paralysis, and cortico-basal degeneration have now been identified. We propose a review of the topic and discuss the contribution of various clinical and pathological features leading to consider motoneuron diseases as neurodegenerative processes included in a broad spectrum of tauopathies.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis / genetics*
  • Amyotrophic Lateral Sclerosis / metabolism
  • Animals
  • Basal Ganglia Diseases / genetics
  • Basal Ganglia Diseases / metabolism
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Mutation / genetics
  • Mutation / physiology
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism
  • Superoxide Dismutase / genetics*
  • Superoxide Dismutase / metabolism*
  • tau Proteins / genetics*
  • tau Proteins / metabolism*

Substances

  • DNA-Binding Proteins
  • tau Proteins
  • Superoxide Dismutase